Answers are grounded in this paper and cite their sources.
Parkinson's disease (PD) is a common and progressively deteriorating neurodegenerative disorder, profoundly affects millions of individuals worldwide. Neuroimaging research has consistently demonstrated abnormalities in quantitative susceptibility mapping (QSM) within the substantia nigra that are associated with Parkinson's disease. However, the genetic underpinnings shared between Parkinson's disease and QSM of substantia nigra remain inadequately understood. Here, genetic pleiotropic analyses were conducted to explore genetic overlap at global, local, and variant levels, leveraging summary statistics from the largest genome-wide association studies for PD (N = 501,348) and QSM of substantia nigra (N = 35,273). We observed a significant global genetic correlation between PD and QSM of substantia nigra ( rg = 0.096, p = 0.032 with LDSC; rg = 0.097, p = 0.048 with SumHer). Local-level analysis identified six genomic regions showing shared associations with the two traits. At the variant level, we found 12 genetic variants shared by PD and QSM of substantia nigra. These shared risk variants were mapped to 33 unique genes. We analyzed drug-gene interactions based on these shared genes and their associations with PD medications. These findings elucidate the genetic interplay between substantia nigral magnetic susceptibility and PD pathogenesis, revealing potential biomarker discovery and targets for therapeutic development.
No takes yet. Share an insight, caveat, or question.
Jilian Fu (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: